🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07258277
Starting soon Not applicable

Adductor Canal Block With IPACK Versus Genicular Nerves Block With IPACK for Post-operative Analgesia

NCT07258277 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-12
Last updated
2025-12-02

Condition(s) studied

Postoperative Analgesia

Investigational drug(s) / intervention(s)

IPACK with adductor canal blockIPACK with Genicular nerves blockSpinal Block

IPACK with adductor canal block: receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then another 15 ml of 0.25% plain bupivacaine at the mid-thigh for the ACB.

IPACK with Genicular nerves block: receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then at the anterior surface of the knee 16 ml of 0.25% plain bupivacaine divided on the 4 genicular nerves (superior medial, superior lateral, inferior medial and inferior lateral).

Spinal Block: won't receive any nerve block, only spinal anesthesia. \- Then spinal anesthesia will be given to all patients in the three groups, 3 ml (15 mg) 0.5% hyperbaric bupivacaine will be administered intrathecal at level of L3-4 or L4-5 interspace.

Study summary

In our study, we will find out the efficacy of those peripheral nerve blocks on postoperative pain in knee arthroscopy.

The aim is to evaluate the efficacy of combined ultrasound-guided IPACK with adductor canal nerve block versus ultrasound-guided IPACK with genicular nerves block on postoperative pain in knee arthroscopy.

Eligibility

Sex
ALL
Min age
20 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * ASA l \& ll * planned to undergo elective unilateral knee surgeries under spinal anesthesia * age between 20 to 70 years old * both sex Exclusion Criteria: * Patient refusal * Neurological deficiencies prior to surgery * Severe Cardiovascular, renal and hepatic comorbidities * Hematological disorders and abnormal coagulation parameters * Psychiatric illnesses and opioid addiction * Allergies to any of the medications will be utilized in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Minia University Hospital Minya Minya Governorate

More Minia University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07258277 on ClinicalTrials.gov ↗ ← All trials in Egypt